Workflow
海正药业销往欧盟市场的产品
icon
Search documents
海正药业(600267.SH):欧盟撤销台州工厂GMP不符合声明
智通财经网· 2025-10-19 09:49
经查询欧盟官方数据库,目前已无法查询到公司台州工厂的《GMP不符合声明》,意味着欧盟已解除 公司台州工厂GMP不符合状态,对公司产品销往欧盟市场及其他市场带来一定的积极影响。 海正药业(600267.SH)公告,欧盟撤销公司台州工厂《GMP不符合声明》,公司二期工程(Y20、Y36、 Y37、Y38和Y39号厂房)的违规声明已于2025年10月17日撤销。 ...
海正药业:欧盟撤销台州工厂GMP不符合声明
Zhi Tong Cai Jing· 2025-10-19 09:45
Core Viewpoint - The European Union has revoked the GMP non-compliance declaration for Haizheng Pharmaceutical's Taizhou factory, positively impacting the company's product sales in the EU and other markets [1] Summary by Relevant Sections - **Regulatory Update** - The EU's revocation of the GMP non-compliance declaration for the Taizhou factory occurred on October 17, 2025 [1] - The official EU database no longer shows the GMP non-compliance status for the Taizhou factory, indicating a return to compliance [1] - **Market Impact** - The lifting of the non-compliance status is expected to have a positive effect on the company's ability to sell products in the EU market and potentially other markets [1]